stock downgrade
UBS Downgrades QuidelOrtho to Sell
The investment bank cited risks in the firm's guidance for respiratory test sales and in the launch of the Savanna point-of-care MDx system.
Barclays Downgrades Thermo Fisher Scientific, Danaher to Equal Weight
The investment bank also downgraded the US life science tools and diagnostics industry from Positive to Neutral citing macroeconomic uncertainty across end markets.
Evercore, Barclays Downgrade Agilent Shares
The investment banks said they made the changes in response to lower demand for instruments in biopharma industries and lower economic activity in China.
BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
In an announcement late Wednesday, the company said Ronnie Andrews had stepped down, marking the firm's third major executive to depart in recent months.
Canaccord Downgrades T2 Biosystems to Hold
The investment bank cited a soft Q3 outlook, slower-than-expected pipeline progress, and capital and liquidity concerns raised in the company's preliminary quarterly results.